January 04, 2021
REDWOOD CITY, Calif. , Jan. 04, 2021 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage ...
Read MoreDecember 11, 2020
Soleno intends to submit plans to FDA to conduct further analyses of clinical data from ...
Read MoreNovember 10, 2020
REDWOOD CITY, Calif. , Nov. 10, 2020 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage ...
Read More